Stereotactic Body Radiotherapy in a Transplanted Lung for a Primary Lung Cancer: Case Report.

ABSTRACT:

Introduction

Lung cancer in the transplanted organ is an extremely rare occurrence with very few cases reported. The use of stereotactic body radiotherapy (SBRT) for medically inoperable early stage non-small cell lung cancer is an option to treat an early stage lung adenocarcinoma on a transplanted lung.

Case presentation

We report the case of a 63-year-old woman with a history of hypersensitivity pneumonitis, who underwent a right lung transplant in 2010 and developed pulmonary adenocarcinoma, stage IA2, in 2023. The patient was ineligible for surgical management and was referred for SBRT. The treatment was administered with a total dose of 48 Gy in 4 fractions in December 2023. The nodule remained stable at 9-month follow-up, with post-radiogenic pneumonitis observed. Pul

SUBMITTER: Ferreira P 

PROVIDER: S-EPMC11731908 | biostudies-literature | 2025 Jan-Dec

REPOSITORIES: biostudies-literature